A new study on hexarelin was published on September 18, 2026. The paper, titled "Histopathological and immunohistochemical characterization of MPTP-associated pancreatic injury and its attenuation by Hexarelin in mice," appeared in the Journal of Molecular Histology.
The publication is listed under PubMed ID 42758352. Hexarelin remains classified as an unapproved research compound. This entry reflects the appearance of the publication itself, not a summary of any findings, data, or conclusions contained within it.
Readers interested in the broader context of this compound can consult the hexarelin overview for additional background.